person · Reporting owner

Ades Alan A.

Disclosed activity across 1 company

Tapewire entity: 84202
SEC CIK: 0001757286

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Organogenesis Holdings Inc.ORGO · Entity 6275	Director · 10% owner	January 09, 2025	January 13, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Organogenesis Holdings Inc.

Report date January 09, 2025 · Filed January 13, 2025

Jointly reported with Ades Josette, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016, Erani Dennis, Wisdom Starr, RED Holdings, LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	51,085,402	Reported balance After 2025-01-09 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2025-01-09 · Gift · Disposed 6,401,945 · Balance 51,085,402 F1: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group.
Class A Common StockSEC Table I · non-derivative	Direct	51,085,402	Reported balance After 2025-01-09 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2025-01-09 · Gift · Acquired 6,401,945 · Balance 51,085,402 F1: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group.
Class A Common StockSEC Table I · non-derivative	IndirectBy spouse	51,085,402	Reported balance After 2025-01-09 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2025-01-09 · Gift · Acquired 6,401,945 · Balance 51,085,402 F1: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group.

Filing footnotes · ownership attribution and instrument terms

F1: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities.

F2: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 29, 2020 Filed Feb 12, 2021 18:29 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GiftClass A Common Stock	251,430	$0.00	$0.00	Disclosure SEC source: 0001661181-21-000006 · edgar.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,794,976 F1 · shares: Such shares were previously held by GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 (the "GN 2016 GRAT"), a member of the Group (as defined below). On December 29, 2020, the GN 2016 GRAT distributed 251,430 shares of Class A Common Stock of Organogenesis Holdings Inc. to Glenn H. Nussdorf in satisfaction of its annuity obligation and in an exempt transaction pursuant to Rule 16a-13. On December 29, 2020, Glenn H. Nussdorf transferred 251,430 shares of Class A Common Stock of Organogenesis Holdings Inc. to GN 2016 Family Trust u/a/d August 12, 2016 for no consideration. Each of Glenn H. Nussdorf and GN 2016 Family Trust u/a/d August 12, 2016 is a member of the Group. Read SEC document
December 29, 2020 Filed Feb 12, 2021 18:29 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GiftClass A Common Stock	251,430	$0.00	$0.00	Disclosure SEC source: 0001661181-21-000006 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,543,546 F1 · shares: Such shares were previously held by GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 (the "GN 2016 GRAT"), a member of the Group (as defined below). On December 29, 2020, the GN 2016 GRAT distributed 251,430 shares of Class A Common Stock of Organogenesis Holdings Inc. to Glenn H. Nussdorf in satisfaction of its annuity obligation and in an exempt transaction pursuant to Rule 16a-13. On December 29, 2020, Glenn H. Nussdorf transferred 251,430 shares of Class A Common Stock of Organogenesis Holdings Inc. to GN 2016 Family Trust u/a/d August 12, 2016 for no consideration. Each of Glenn H. Nussdorf and GN 2016 Family Trust u/a/d August 12, 2016 is a member of the Group. Read SEC document
November 17, 2020 Filed Nov 19, 2020 16:53 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	PurchaseClass A Common Stock	347,153	$3.25	$1,128,247.25	Disclosure SEC source: 0001661181-20-000036 · edgar.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Robert Harry Erani Frick Trust Disclosed balance after: 68,794,976 F2 · shares: The reported securities were purchased by the Robert Harry Erani Frick Trust (the "Trust") and are held indirectly by Dennis Erani, who is a member of the Group. Susan Erani, Dennis Erani's spouse, and Glenn Nussdorf are co-trustees of the Trust. Dennis Erani disclaims beneficial ownership of the securities held by the Trust, except to the extent of his pecuniary interest therein. Read SEC document
November 17, 2020 Filed Nov 19, 2020 16:53 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	PurchaseClass A Common Stock	486,000	$3.25	$1,579,500.00	Disclosure SEC source: 0001661181-20-000036 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,447,823 F1 · shares: The reported securities were purchased and are held directly by Alan A. Ades, who is a member of the Group. Read SEC document
September 06, 2019 Filed Sep 10, 2019 18:30 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	PurchaseClass A Common Stock	10,000	$5.03	$50,274.00	Disclosure SEC source: 0001661181-19-000015 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,961,823 F1 · shares: The reported securities were purchased and are held directly by Alan A. Ades, who is a member of the Group (as defined below). F2 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.70 to $5.15, inclusive. The reporting person undertakes to provide to Organogenesis Holdings Inc. ("ORGO"), any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document
September 05, 2019 Filed Sep 5, 2019 20:09 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	PurchaseClass A Common Stock	5,000	$4.53	$22,664.00	Disclosure SEC source: 0001661181-19-000005 · edgar.xml · nonDerivative · entry 4 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,951,823 F5 · shares: The reported securities were purchased and are held directly by Albert Erani, who is a member of the Group. F6 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.52 to $4.55, inclusive. The reporting person undertakes to provide to ORGO, any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (6) to this Form 4. Read SEC document
September 04, 2019 Filed Sep 5, 2019 20:09 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	PurchaseClass A Common Stock	50,000	$4.62	$231,190.00	Disclosure SEC source: 0001661181-19-000005 · edgar.xml · nonDerivative · entry 3 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,946,823 F1 · shares: The reported securities were purchased and are held directly by Glenn H. Nussdorf, who is a member of the Group (as defined below). F4 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.37 to $4.92, inclusive. The reporting person undertakes to provide to ORGO, any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document
September 03, 2019 Filed Sep 5, 2019 20:09 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	PurchaseClass A Common Stock	100	$4.25	$425.00	Disclosure SEC source: 0001661181-19-000005 · edgar.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,896,823 F3 · shares: The reported securities were purchased and are held directly by Dennis Erani, who is a member of the Group. Read SEC document
September 03, 2019 Filed Sep 5, 2019 20:09 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	PurchaseClass A Common Stock	50,000	$4.38	$218,930.00	Disclosure SEC source: 0001661181-19-000005 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,896,723 F1 · shares: The reported securities were purchased and are held directly by Glenn H. Nussdorf, who is a member of the Group (as defined below). F2 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.28 to $4.48, inclusive. The reporting person undertakes to provide to Organogenesis Holdings Inc. ("ORGO"), any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document
December 10, 2018 Filed Dec 12, 2018 21:09 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GrantCommon Stock	182,841	Not disclosed	Not disclosed	Disclosure SEC source: 0001661181-18-000047 · edgar.xml · nonDerivative · entry 3 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,846,723 F5 · price: Received by Glenn H. Nussdorf in connection with the Merger in exchange for 90,069 shares of common stock of Organogenesis previously held by Mr. Nussdorf. F6 · ownership.direct: The reported securities are held directly by Glenn H. Nussdorf, who is a member of the Group. Read SEC document
December 10, 2018 Filed Dec 12, 2018 21:09 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GrantCommon Stock	781,904	Not disclosed	Not disclosed	Disclosure SEC source: 0001661181-18-000047 · edgar.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,663,882 F3 · price: Received by Albert Erani in connection with the Merger in exchange for 385,174 shares of common stock of Organogenesis previously held by Mr. Erani. F4 · ownership.direct: The reported securities are held directly by Albert Erani, who is a member of the Group. Read SEC document
December 10, 2018 Filed Dec 12, 2018 21:09 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GrantCommon Stock	6,279,441	Not disclosed	Not disclosed	Disclosure SEC source: 0001661181-18-000047 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,881,978 F1 · price: Received by Alan A. Ades in connection with the Issuer's business combination (the "Merger") with Organogenesis Inc. ("Organogenesis") in accordance with the terms of the Agreement and Plan of Merger dated as of August 17, 2018 among the Issuer, which was then referred to as Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc. and Organogenesis, in exchange for 3,093,320 shares of common stock of Organogenesis previously held by Mr. Ades. F2 · ownership.direct: The reported securities are held directly by Alan A. Ades, who is a member of the Group (as defined below). Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.